Ithaca, NY, United States of America

Douglas Cordeau

This inventor holds 1 USPTO granted patent. Top assignee: Gilead Sciences, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas Cordeau. Retrieved from https://idiyas.com/inventor/douglas-cordeau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Douglas Cordeau: Innovator in Pharmaceutical Methods

Introduction

Douglas Cordeau is a notable inventor based in Ithaca, NY (US). He has made significant contributions to the field of pharmaceuticals through his innovative methods and intermediates for preparing pharmaceutical agents. His work is essential in advancing the development of new medications.

Latest Patents

Cordeau holds a patent for "Methods and intermediates for preparing pharmaceutical agents." This invention provides methods and intermediates that are useful for preparing a compound of formula I and salts thereof. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Douglas Cordeau is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to work on cutting-edge research and development in the pharmaceutical industry. His contributions are vital to the company's mission of advancing innovative therapies.

Collaborations

Cordeau has collaborated with notable colleagues, including Richard P. Polniaszek and Steven S. Pfeiffer. These partnerships enhance the collaborative environment necessary for groundbreaking research and development in pharmaceuticals.

Conclusion

Douglas Cordeau is a distinguished inventor whose work in pharmaceutical methods has made a significant impact on the industry. His innovative approaches continue to pave the way for advancements in medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…